 |
 |

Racial Disparities in Rectal Cancer Treatment
A Population-Based Analysis
Arden M. Morris, MD, MPH;
Kevin G. Billingsley, MD;
Nancy N. Baxter, MD, PhD;
Laura-Mae Baldwin, MD, MPH
Arch Surg. 2004;139:151-155.
Hypothesis We hypothesized that there are significant racial disparities in delivery of care to rectal cancer patients. We examined differential surgical and radiation treatment for these patients and determined whether blacks were less likely than whites to undergo sphincter-sparing procedures, which are associated with a higher quality of life than sphincter-ablating procedures.
Design Cross-sectional cohort study.
Patients and Setting The Surveillance Epidemiology and End Results database provided population-based data for rectal cancer patients who were diagnosed between 1988 and 1999, were older than 35 years, and had no prior colorectal or other pelvic cancer.
Main Outcome Measures Using logistic regression, we compared receipt and type of surgical therapy and radiation therapy, controlling for age, sex, year, geography, stage, and anatomic location.
Results Among 52 864 patients, 3851 were black and 44 010 were white. Blacks were younger than whites and had more advanced disease (P<.001). Among patients who underwent operation, rates of sphincter-ablating procedure were 37% for whites and 43% for blacks (adjusted odds ratio [AOR], 1.42; 95% confidence interval [CI], 1.23-1.65). Moreover, 53% of whites and 56% of blacks received no radiation therapy for stage II to III disease (AOR, 1.30; 95% CI, 1.15-1.47).
Conclusions Blacks with rectal cancer were diagnosed at a younger age and more advanced disease stage than whites, implying a need for more aggressive screening. After adjusting for stage and other covariates, surgical and radiation treatment also differed along racial lines. Our data suggest that treatment disparities may contribute to differences in outcome among racial/ethnic groups with rectal cancer, and they highlight the need for improving access to state-of-the-art surgical care for minority patients with rectal cancer.
From the Department of Surgery, Section of Colon and Rectal Surgery, University of Minnesota, Minneapolis (Drs Morris and Baxter); and the Departments of Surgery (Dr Billingsley) and Family Practice (Dr Baldwin), University of Washington, Seattle.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Racial Disparities in Rectal Cancer TreatmentInvited Critique
Michael J. Stamos
Arch Surg. 2004;139(2):156.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Insurance Status, Comorbidity Level, and Survival Among Colorectal Cancer Patients Age 18 to 64 Years in the National Cancer Data Base From 2003 to 2005
Robbins et al.
JCO 2009;27:3627-3633.
ABSTRACT
| FULL TEXT
Effect of Race and Insurance Status on Presentation, Treatment, and Mortality in Patients Undergoing Surgery for Diverticulitis
Lidor et al.
Arch Surg 2008;143:1160-1165.
ABSTRACT
| FULL TEXT
Effects of Socioeconomic Status and Treatment Disparities in Colorectal Cancer Survival
Le et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1950-1962.
ABSTRACT
| FULL TEXT
Racial Disparities in Treatment and Survival of Male Breast Cancer
Crew et al.
JCO 2007;25:1089-1098.
ABSTRACT
| FULL TEXT
Telephone Outreach to Increase Colorectal Cancer Screening in an Urban Minority Population
Basch et al.
AJPH 2006;96:2246-2253.
ABSTRACT
| FULL TEXT
|